Navigation Links
Angiotech to Establish Separate Operating and Royalty Businesses
Date:7/7/2008

other uses of

paclitaxel licensed to BSC and Cook (including uses relating to

Cook's ZILVER(R) PTX paclitaxel-eluting peripheral vascular stent);

(iii) potential royalty and other income from certain other uses of

paclitaxel licensed to Broncus Technologies Incorporated ("Broncus")

relating to the Exhale(R) paclitaxel-eluting lung stent; and (iv)

certain other assets and liabilities not related to the ongoing

business of API. The business of Angiotech prior to the transaction

consists primarily of the business assets to be transferred to API,

and the license agreements with BSC, Cook and Broncus. For the year

ended December 31, 2007, Angiotech had $288 million in revenue, $111

million of which was royalty revenue derived mainly from BSC, and

$177 million of which was product and royalty revenue derived from

the assets to be transferred to API.

- Financing Transaction. The Company has entered into a Note Purchase

Agreement, providing for the issuance and sale of between

$200 million and $300 million of convertible notes to Ares Management

and New Leaf Venture Partners. The convertible notes will have an

initial conversion price of $20 per share, and each $1,000 principal

amount of convertible notes will be convertible into 50 shares of

API, implying an initial equity value for API of $625 million

assuming $75 million in cash and cash equivalents at API at closing

and no debt, other than the guarantees of remaining amounts of

Angiotech's two existing debt issues. The convertible notes will be

convertible into 32% to 48% of the common stock of API, depending

upon the final initial transaction size, calculated on an "if

converted" basis and without taking into account any future dilution

resulting from ad
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Meet ARGUS, The World,s ... & Read People. Analyze emotions and predict actions. Explore ... the very first Responsive-RPG: "The Eye: Genesis". ... , , , https://www.youtube.com/watch?v=B1ZEtAZ2Yf8 ... your inner feelings - and those of others. Being ...
(Date:6/2/2015)... 2, 2015   Hospira, Inc. (NYSE: ... that its partner, Celltrion – a global biopharmaceutical company – ... Surveillance Agency in Brazil – ... for use in Brazil . The ... and sells biosimilar infliximab in 26 European countries and ...
(Date:6/2/2015)... Pa. , June 2, 2015   BioClinica ... and technology provider, today announced that David Peters ... been named Executive Vice President and Chief Financial Officer ... 2015. Peters brings more than 25 years ... pharmaceutical services. "David has extensive and deep knowledge in ...
(Date:6/2/2015)... June 2, 2015  RXi Pharmaceuticals Corporation ... focused on discovering and developing innovative therapies ... ophthalmology, today announced that Dr. Pamela Pavco ... at the 23 rd World Congress ... will include in-depth presentations by world-class clinicians ...
Breaking Biology Technology:ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 2ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 3ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5BioClinica Names David Peters New Chief Financial Officer 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4
... , Baltimore Convention Center ... BALTIMORE, Aug. 11 This summit will attract more than 1,200 ... It will feature more than 100 speakers, including governors, federal officials, ... cell policies, scientific breakthroughs, and human-interest stories. This is your ...
... , SAN FRANCISCO, Aug. 11 ... stage biopharmaceutical company developing a proprietary breakthrough class of targeted ... private placement financing with gross proceeds of US $5,123,521, exceeding ... anticipated on or before September 15, 2009, with additional proceeds ...
... 11 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: ... to improving health through the development, manufacture and,commercialization of ... ("OTC"),products in China, announced today that the Audit Committee ... of Ernst & Young Hua Ming ("EY") as,the Company,s ...
Cached Biology Technology:World Stem Cell Summit to Be Held in Baltimore 2Jennerex Closes $5 Million First Tranche of Series C Financing 2
(Date:6/1/2015)... According to a new market research report ... & Touchless), Application (Consumer Electronics, Automotive, & Others), Product ... Forecast to 2020", published by MarketsandMarkets, the Gesture Recognition ... Billion by 2020, at a CAGR of 28.23% between ... data T ables and   86   F ...
(Date:6/1/2015)... , June 1, 2015 ... "Next Generation Biometrics Market by Application (Government, Military ... Travel & Immigration, and Security), Technology (Face Recognition, ... Signature Recognition, Vein Recognition, and Others), Function (Contact ... , Europe , APAC, ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of the "Facial Recognition Market ... User - Global Forecast to 2020" report ... years, have seen facial recognition technology become more ... technology to gain traction and investment from the ...
Breaking Biology News(10 mins):Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2
... Two proteins interact in a previously unknown molecular mechanism ... for the causes of defective organs in fetuses, metastatic ... Children,s Hospital Medical Center. Reporting their work in ... researchers said the mechanism coordinates cell identity and behavior ...
... shells to bones, the skeletons of organisms contain small ... levels of these elements provide important clues to past ... to relate impurity contents to the ancient environments in ... 31 issue of Science magazine, Allison Stephenson, ...
... have unlocked part of the mystery underlying a childhood eye disease. ... end up with missing or extra pieces of DNA. The ... (CNVs). The U of A research team had previously shown how ... glaucoma a disease that can lead to blindness. In their ...
Cached Biology News:New regulatory mechanism discovered for cell identify and behavior in forming organs 2New regulatory mechanism discovered for cell identify and behavior in forming organs 3Bare bones of crystal growth: Biomolecules enhance metal contents in calcite 2
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
... WinList come straight from the folks who ... automatic region positioning, N-Stat regions, and presentation-quality ... thoughtful conversations, and careful design. Of course, ... are still there, too. WinList leads the ...
C/EBPdelta Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Biology Products: